Endometriosis pain staging: matching clinical profiles to laparoscopy
A patient with stage I endometriosis can have pain that makes ordinary daily activity difficult. A patient with stage IV disease can report little or no pain.

The revised American Society for Reproductive Medicine classification, or rASRM, describes what a surgeon sees at laparoscopy. It does not grade the patient’s pain.
The distinction matters when deciding what to do next. A low stage does not make severe symptoms less real, and a high stage does not, by itself, settle whether surgery is the right choice. NICE and ESHRE guidance both support decisions shaped by symptoms and the individual’s circumstances, including preferences and priorities. The stage is one part of the clinical record; it is not a treatment instruction.
Decoding rASRM Surgical Scores Versus Patient Pain Profiles
The rASRM system assigns points to operative findings, including the location, size, and depth of endometriosis lesions and the presence and density of adhesions. The total score places disease into one of four stages: stage I, 1 to 5 points, is minimal; stage II, 6 to 15, is mild; stage III, 16 to 40, is moderate; and stage IV, more than 40, is severe.
Those labels describe the extent of disease recorded during surgery. They do not measure pain, fatigue, the effect of symptoms on work or relationships, or how predictable and disruptive a person’s flares are. Nor do they explain why one person with limited visible disease has severe symptoms while another with extensive disease has few.
Pain assessment needs its own account. That means asking how symptoms behave across the menstrual cycle, what activities they affect, whether sex is painful, and whether bowel or urinary symptoms recur in a cyclical pattern. The duration and day-to-day impact of pelvic pain also matter. A stage number cannot substitute for that conversation.
The operative score still has value. It gives clinicians a shared way to describe findings and can help make operative notes easier to compare. But a useful record should include the findings behind the score: where lesions were seen, what structures were involved, whether adhesions were present, and what disease was treated or left in place. A number without that context is a thin account of a complex operation.
The practical mistake is to let the stage answer a question it was not designed to answer. A low score should not be used to dismiss substantial pain. A high score should not automatically trigger surgery without considering the person’s symptoms, goals, and treatment options.
Navigating Diagnostic Pathways When Pelvic Imaging Appears Normal
A normal pelvic scan does not rule out endometriosis. Ultrasound and MRI can help identify endometriomas and some forms of deep disease, but superficial peritoneal lesions may not be visible. A scan therefore contributes to the assessment without always settling the diagnosis.
NICE allows clinicians to consider laparoscopy when endometriosis is suspected, including when ultrasound or MRI is normal. That recommendation gives patients and clinicians room to discuss the procedure where symptoms and other findings continue to raise concern. It does not make laparoscopy automatic after a normal scan, and it does not mean that every person with pelvic pain needs surgery.
The next step depends on the pattern of symptoms, the examination, imaging findings, previous treatment, and the patient’s preferences. Where deep disease is suspected, specialist imaging can help map its location and inform referral and surgical planning. When imaging is normal and symptoms remain troublesome, the options may include empirical treatment, further assessment, or a discussion of diagnostic laparoscopy.
A useful consultation keeps several questions in view:
- What symptoms are present, how long have they been occurring, and how much do they affect daily life?
- Is there a cyclical pattern to pain, bowel symptoms, urinary symptoms, or pain during sex?
- What did the examination and imaging show, and what might those tests not have detected?
- Has medical treatment been tried? If so, what changed, and were there unwanted effects?
- What would the patient hope to gain from laparoscopy, and what uncertainties or risks would affect that decision?
This is not a fixed sequence in which every person proceeds through the same tests and reaches the same endpoint. It is a way of making the reasoning visible. ESHRE recognizes both empirical treatment and diagnostic laparoscopy as possible approaches; the choice depends on the clinical situation and the patient’s preferences.
A normal scan can leave an important question open. It does not, by itself, decide either for or against laparoscopy.
Evaluating Empirical Treatment Choices Under NICE and ESHRE
Empirical treatment means starting symptom management without first confirming endometriosis at surgery. Depending on the clinical picture and the patient’s circumstances, options can include pain relief such as nonsteroidal anti-inflammatory drugs and hormonal suppression. Hormonal options may include combined oral contraceptives, progestogens, or a levonorgestrel-releasing intrauterine system. Suitability depends on individual health factors, side effects, contraceptive needs, and preferences; the options are not interchangeable for everyone.
NICE supports considering treatment based on symptoms and the patient’s priorities rather than requiring a surgical diagnosis first. ESHRE’s guidance also treats empirical treatment and diagnostic laparoscopy as alternatives for managing suspected endometriosis. That does not mean they provide identical information. Medical treatment may help control symptoms, but it does not show what lesions are present or assign an rASRM stage. Laparoscopy can provide operative findings, but it involves surgery and its own risks.
For someone with symptoms consistent with endometriosis, no concerning examination or imaging findings, and a preference to avoid surgery, a trial of medical management may be reasonable. A different discussion may be needed if symptoms persist despite treatment, treatment is unsuitable or unwanted, or findings raise concern about deep disease. In those circumstances, clinicians may consider specialist imaging, referral, and whether laparoscopy would add information or offer a treatment opportunity.
It helps to separate three questions that are often bundled together:
1. What is the most likely explanation for the symptoms? Endometriosis may be suspected from the history and examination, but other causes of pelvic pain may also need consideration.
2. What can be tried without surgery? The answer depends on previous treatment, medical suitability, and the patient’s priorities.
3. What would laparoscopy change? It may clarify operative findings and allow treatment of visible disease, but its likely value should be weighed against the uncertainty and surgical burden.
A response to hormonal treatment does not prove endometriosis, just as a lack of response does not rule it out. Treatment response is one part of the clinical picture. The same is true of imaging: a positive finding may help guide planning, while a normal result may leave uncertainty.
| Clinical picture | Possible next discussion |
|---|---|
| Symptoms fit suspected endometriosis, and the patient prefers to avoid surgery | Whether empirical pain relief or hormonal treatment is suitable |
| Symptoms continue despite treatment, or treatment is unsuitable or unwanted | Whether further assessment or diagnostic laparoscopy would be useful |
| Deep disease is suspected from symptoms, examination, or imaging | Referral and specialist imaging to inform planning |
| Imaging is normal but symptoms remain significant | How uncertainty affects the choice between continued medical management and laparoscopy |
The table is a guide to the questions, not a decision rule. The same scan result or symptom pattern can lead to different choices because treatment history, fertility plans, other health considerations, and personal preferences differ.
Weighing Patient Priorities and Fertility Goals in Surgical Planning
A decision about laparoscopy should begin with what the patient wants the treatment to address. For some, pain relief is the main priority. Others are weighing symptoms against plans for pregnancy, concerns about ovarian reserve, or a wish to avoid surgery. Those priorities can affect whether surgery is considered and, if it is, how extensive an operation is planned.
Fertility discussions need particular care when ovarian endometriomas or previous ovarian surgery are part of the picture. Surgery on an ovary can have implications for ovarian reserve, so the potential benefits and harms should be discussed in the context of the individual’s history and plans. Tests such as anti-Müllerian hormone and antral follicle count may be considered as part of that assessment. They contribute information; they do not, on their own, decide whether surgery is appropriate or predict an individual outcome with certainty.
The goals of an operation can also differ. Treating visible disease with pain relief in mind may involve different considerations from a plan shaped by fertility priorities. The extent and location of disease, the condition of the ovaries, prior operations, and the patient’s preferences all matter. A surgical plan should explain what the team expects to treat and where important uncertainties remain.
The consultation is more useful when it records the reasoning, not just the proposed procedure. A clear plan can describe:
- The working diagnosis and what remains uncertain.
- The symptoms the patient most wants to address.
- Relevant examination and imaging findings, explained in plain language.
- The options considered, including medical management, observation, and surgery.
- What an operation might involve, such as excision, ablation, or treatment of adhesions, where relevant.
- How fertility goals and ovarian considerations affect the discussion.
- The expected recovery in the context of the proposed procedure, including whether more extensive surgery is anticipated.
Recovery varies with the operation and the person. A straightforward diagnostic procedure and surgery for deep disease involving other organs are not the same experience. It is therefore more helpful to discuss the likely recovery for the planned operation than to promise a single timetable. The conversation should also cover when to seek advice after surgery and what follow-up will look like.
Documenting Operative Findings and Minimizing Surgical Risks
When laparoscopy is chosen, the operative record should make the findings understandable to the patient and useful to other clinicians. NICE recommends that laparoscopic surgery for endometriosis be accompanied by recording of the findings, including intra-operative imaging. That does not mean NICE requires a particular rASRM form. The important point is that the record should describe what the surgeon found rather than rely on a stage label alone.
A useful operative note can document lesion sites and appearance, adhesions, structures involved, what was treated, and whether any disease was left in place. Images can add context to the written record. Together, these details help the original team explain the operation and allow clinicians involved later to understand the findings without having to infer them from a score.
The scope of surgery also affects risk. Diagnostic laparoscopy and surgery for deep infiltrating disease are different procedures. When disease may involve bowel, bladder, ureter, or other structures, planning should account for that complexity. The patient should hear which risks are relevant to the proposed operation, what the team would do if unexpected findings arise, and whether specialist colleagues may need to be involved.
Consent is not just a list of complications. It is a discussion of what the operation is intended to achieve, what it may not achieve, and what alternatives remain. The likely balance changes with disease location, the extent of planned surgery, prior operations, and individual health factors. Where a procedure is more complex, the consultation should make clear why it is being proposed and how its risks compare with the expected benefit for that patient.
The operative report should also preserve uncertainty honestly. If no visible disease is found, that does not necessarily explain every symptom. If disease is found, its stage does not prove that it is the sole cause of pain. The findings inform the next part of care; they do not replace follow-up or reassessment.
The rASRM stage is a description of operative findings, not a forecast of how much pain a person should feel. The treatment decision belongs in the wider clinical picture.
The most useful question is not whether a stage sounds mild or severe. It is what the symptoms, examination, imaging, treatment history, and patient priorities together suggest should happen next. For one person, that may mean trying medical management; for another, discussing laparoscopy or specialist assessment. A good plan explains why that option fits, what it can and cannot answer, and how the decision may change if symptoms or priorities change.